AI-first MRI research

AI-assisted MRI insight for earlier Alzheimer's detection.

NoevisAI is a company that builds AI-first research tools that help teams analyze MRI scans, surface early neurodegenerative signals, and support faster, evidence-driven Alzheimer's research workflows.

Mission built for scientific velocity.

We believe open innovation, rigorous science, and human-centered design can accelerate discovery. NoevisAI pairs expert researchers with intelligent agents that automate complex workflows, helping teams move from raw data to trusted insight faster.

Why NoevisAI

Traditional bioinformatics tools are accurate but slow to scale. We merge GPU computation, adaptive AI scoring, and agentic orchestration to deliver fast, reproducible analysis without sacrificing interpretability or collaboration.

Platform pillars

A unified system for bioinformatics workflows that keeps research agile and evidence-driven.

GPU-accelerated alignment

Modernized Smith-Waterman workflows that scale to massive datasets while preserving sensitivity.

Agentic intelligence

Interactive agents that triage jobs, summarize findings, and adapt pipelines to each study.

Open research fabric

Extensible SDKs and data exchange standards built for community collaboration and transparency.

Focus areas

We start with early dementia detection and expand across chronic diseases, clinical trials, and computational biology.

Healthcare

  • Early dementia diagnostics support for clinicians
  • Extensible roadmap toward diabetes and metabolic disorders
  • Patient-first workflows aligned to care teams

Pharma

  • Sequence alignment at scale for genomic programs
  • Classification models for neurodegeneration research
  • Secure, standardized collaboration across partners

Academia

  • Open-source SDKs for research labs
  • Support for student-led experiments and courses
  • Reproducible science with shared extensions

Product stack

Modular tools that let teams deploy quickly while staying open to new research directions.

CogniScan MRI Predictor

MRI-derived risk stratification workflows for early Alzheimer's research and cohort enrichment. Explore the product

Ready to collaborate?

Partner with NoevisAI to accelerate discovery, modernize diagnostic workflows, and make data-driven medicine more accessible.